<?xml version="1.0" encoding="utf-8"?>
<iati-activities xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" version="2.03" generated-datetime="2026-02-14T15:41:46.5705883+01:00" linked-data-default="http://data-service.theglobalfund.org/api">
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-BDI-C-UNDP-2</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">PACTE-TB/VIH : Programme d’Accélération vers le Contrôle de la Transmission de l’Epidémie du VIH et de la Tuberculose au Burundi - Burundi (01-Jan-2021-31-Dec-2023)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Burundi, TB/HIV, United Nations Development Programme (UNDP Burundi)This program has the following goals: Intensifier la prévention des nouvelles infections par voie sexuelle et sanguine chez les adolescents et jeunes et parmi les populations clés  Intensify prevention of new sexual and blood-borne infections among adolescents and young people and key populations..  Renforcer la prévention de la transmission du VIH de la mère à l’enfant, la prise en charge pédiatrique précoce et le maintien de leurs mères en vie.  Strengthen prevention of mother-to-child transmission of HIV, early paediatric care and keeping mothers alive..  Baisser la mortalité liée au VIH/sida  Reduce HIV/AIDS-related mortality.  Atténuer l’impact et les déterminants de la vulnérabilité liée au VIH sur les populations vulnérables  Mitigating the impact and determinants of HIV-related vulnerability on vulnerable populations..  Renforcer et améliorer la gestion et coordination de la réponse nationale dans l’esprit des « Three ones »  Strengthen and improve the management and coordination of the national response in the spirit of the  Three Ones ..  Mettre fin à la tendance épidémique de la tuberculose au Burundi afin de libérer la population du fardeau lié à la TB et ses comorbidités pour sa participation au développement du pays.  To put an end to the epidemic trend of tuberculosis in Burundi in order to free the population from the burden of TB and its co-morbidities for its participation in the development of the country.. The objectives of this program are: Le nombre de nouvelles infections à VIH est réduit de 20% dans la population générale et dans les groupes les plus exposés au risque VIH de 2018 à 2022  The number of new HIV infections is reduced by 20% in the general population and in most-at-risk groups between 2018 and 2022..  Le risque de TME est réduit de 13.88% en 2017 à 2% en 2022  MCT risk is reduced from 13.88% in 2017 to 2% in 2022.  La mortalité liée au VIH et au SIDA est réduite de 34% de 2018 à 2022  HIV and AIDS mortality is reduced by 34% from 2018 to 2022..  Les conditions de vie d'au moins 80% des personnes infectées et affectées par le VIH et sida et démunies sont améliorées d’ici à 2022  The living conditions of at least 80% of people infected and affected by HIV and AIDS and the poor are improved by 2022..  La gestion de la réponse nationale au VIH et au sida est efficace, efficiente et performante, dans le respect des « Three ones »   The management of the national response to HIV and AIDS is effective, efficient and efficient, in line with the  Three ones ..  Assurer le dépistage  et le diagnostic de 121,666 présumés de tuberculose y compris les enfants et autres groupes à risque attendus de 2021 à 2023, à raison de 8099 en 2021, de 8909 en 2022 et de 9800 en 2023.  To screen and diagnose 121,666 suspected tuberculosis patients, including children and other at-risk groups expected from 2021 to 2023, at a rate of 8099 in 2021, 8909 in 2022, and 9800 in 2023 ..  Dépister et traiter 636 patients TB/MR de 2021 à 2023 dont 166 en 2021, 211 en 2022 et 259 en 2023, soit une augmentation taux de 12,8% en 2018 à 61, 2% en 2023.  Detect and treat 636 MDR/TB patients from 2021 to 2023, including 166 in 2021, 211 in 2022 and 259 in 2023, a rate increase from 12.8% in 2018 to 61.2% in 2023 ..  Maintenir respectivement, le taux de succès thérapeutique à plus de 93%  chez les nouveaux patients tuberculeux et à plus de 90% chez les nouveaux patients TB/MR, de 2021 à 2023.  Maintain, respectively, a treatment success rate of more than 93% in new TB patients and more than 90% in new MDR/TB patients from 2021 to 2023..  Tester au VIH  100% des tuberculeux et mettre sous traitement antirétroviral 100% des patients coinfectés TB/VIH, de 2021 à 2023.  Test 100% of tuberculosis patients for HIV and putting 100% of TB/HIV co-infected patients on antiretroviral treatment, from 2021 to 2023..  Améliorer les capacités de gestion du programme de lutte antituberculeuse: améliorer la surveillance, le système de suivi/évaluation et de recherche opérationnelle.  Improve the management capacity of the tuberculosis control program: improve the surveillance, monitoring/evaluation and operational research system.</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="BDI-C-UNDPP02" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2021-01-01" />
		<activity-date type="2" iso-date="2021-01-01" />
		<activity-date type="3" iso-date="2023-12-31" />
		<activity-date type="4" iso-date="2023-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Gilles, CESARI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>gilles.cesari@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="BI" percentage="100">
			<narrative xml:lang="en">Burundi</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="69">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="15">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="2">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="14">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 2: Preventing unintended pregnancies among women living with HIV</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="7">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Community empowerment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Condom and lubricant programing</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Prevention and management of co-infections and co-morbidities (Prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy (“Know Your Rights” campaign)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="41">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Orphan and vulnerable children package</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention and management of co-infections and co-morbidities (Treatment, care and support)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - ARV toxicity</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="15">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Prevention (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="9">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Key populations (TB/HIV) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; Treatment (TB/HIV)</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2023-01-01" />
			<period-end iso-date="2023-12-31" />
			<value currency="USD" value-date="2021-01-01">24433978.48</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2021-01-01" />
			<period-end iso-date="2021-12-31" />
			<value currency="USD" value-date="2021-01-01">7731670.37</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2022-01-01" />
			<period-end iso-date="2022-12-31" />
			<value currency="USD" value-date="2021-01-01">12674813.20</value>
		</budget>
		<transaction ref="2301765c-05c4-4c4a-bf8b-231dc46ca764">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-07-15" />
			<value currency="USD" value-date="2025-07-15">-242973.87</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="44a12b6c-d53c-4e63-8273-e7e0577cb307">
			<transaction-type code="2" />
			<transaction-date iso-date="2025-06-27" />
			<value currency="USD" value-date="2025-06-27">-2013036.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="800928cb-cfc8-474e-a40d-f18faf0f3c93">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-12-11" />
			<value currency="USD" value-date="2023-12-11">-4321.92</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e6dac6d8-f93e-4610-977e-f1506b492fa7">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-09-30" />
			<value currency="USD" value-date="2024-09-30">-13230.08</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="1896ebf4-e97d-40e7-8bae-19f06d06c68a">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-08-25" />
			<value currency="USD" value-date="2023-08-25">-1590860.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a229c242-dbf1-4f9c-ad6c-d2484456e943">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-08-30" />
			<value currency="USD" value-date="2023-08-30">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="59471be8-f756-4e41-a40c-8404d87332aa">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-09" />
			<value currency="USD" value-date="2022-12-09">15212806.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="fd0c779d-3c09-4170-81c5-2608b4d2535b">
			<transaction-type code="2" />
			<transaction-date iso-date="2023-08-25" />
			<value currency="USD" value-date="2023-08-25">1500000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="31b17b74-5f27-41ef-b4e9-732785031b6a">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-12-09" />
			<value currency="USD" value-date="2022-12-09">-1760206.08</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b6fe9799-90e9-48f7-82f8-e3ccfcb6b857">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-07-07" />
			<value currency="USD" value-date="2021-07-07">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c5a041af-007b-4610-94b5-b15a188377d8">
			<transaction-type code="2" />
			<transaction-date iso-date="2024-04-05" />
			<value currency="USD" value-date="2024-04-05">-8180.80</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="919a1f6e-bbee-4149-921b-e5720b9a5dd2">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-12-17" />
			<value currency="USD" value-date="2020-12-17">26823062.87</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="edafaee2-3976-4b7e-94a5-a2ae50850e42">
			<transaction-type code="7" />
			<transaction-date iso-date="2025-06-30" />
			<value currency="USD" value-date="2025-06-30">-2013036.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="29918533-9de9-4649-9c86-943a499098fa">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-02-10" />
			<value currency="USD" value-date="2022-02-10">9423548.45</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="83f94b10-bb6d-4364-90bd-8b303e9fce5f">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-12-14" />
			<value currency="USD" value-date="2023-12-14">1257026.13</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="74431b4b-a443-4d4c-a305-3bb3d08ad636">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-06-04" />
			<value currency="USD" value-date="2021-06-04">4713949.65</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="26736eb9-4893-4a37-8411-c14227e32587">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-10-01" />
			<value currency="USD" value-date="2024-10-01">-13230.08</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="63b342c7-a735-44d8-946b-1a5d3b15491a">
			<transaction-type code="3" />
			<transaction-date iso-date="2023-08-31" />
			<value currency="USD" value-date="2023-08-31">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="431ecc6d-8e37-4795-9fe2-6b1181883ae6">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-12-13" />
			<value currency="USD" value-date="2022-12-13">13621946.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="d3f34a57-de1e-4d0d-a48f-451d72790c7b">
			<transaction-type code="3" />
			<transaction-date iso-date="2021-11-11" />
			<value currency="USD" value-date="2021-11-11">1653756.90</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="09928c57-6493-4f72-9d3c-1d86ddbf4e36">
			<transaction-type code="7" />
			<transaction-date iso-date="2023-12-06" />
			<value currency="USD" value-date="2023-12-06">-4321.92</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="c2bdc9a0-d379-4535-a1d5-3ace7f4da673">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-12-22" />
			<value currency="USD" value-date="2020-12-22">9271601.79</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="0f58182a-539b-4f52-83ba-4dae63573d23">
			<transaction-type code="7" />
			<transaction-date iso-date="2024-04-01" />
			<value currency="USD" value-date="2024-04-01">-8180.80</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="8e934ac4-be95-4ed9-ba32-de2b1143c9d2">
			<transaction-type code="3" />
			<transaction-date iso-date="2022-11-02" />
			<value currency="USD" value-date="2022-11-02">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP02.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/BDI-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for BDI-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="48.85" />
					<actual value="53.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="97.70" />
					<actual value="121.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="48.85" />
					<actual value="54.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="97.70" />
					<actual value="120.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="97.70" />
					<actual value="128.50" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="97.70" />
					<actual value="120.60" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="97.70" />
					<actual value="128.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="48.85" />
					<actual value="56.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="97.70" />
					<actual value="121.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="89.27" />
					<actual value="47.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="89.27" />
					<actual value="50.20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="82.53" />
					<actual value="46.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="95.05" />
					<actual value="35.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="95.10" />
					<actual value="39.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="95.05" />
					<actual value="44.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="89.30" />
					<actual value="48.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="82.50" />
					<actual value="44.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="82.53" />
					<actual value="41.90" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="130" />
					<actual value="30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="105" />
					<actual value="24" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="166" />
					<actual value="46" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="130" />
					<actual value="20" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="83" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="105" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="83" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="210" />
					<actual value="47" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="260" />
					<actual value="50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive results among the total HIV tests performed during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.47" />
					<actual value="0.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1.43" />
					<actual value="0.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1.63" />
					<actual value="1.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="1.60" />
					<actual value="1.10" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1.40" />
					<actual value="0.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="1.63" />
					<actual value="1.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="1.43" />
					<actual value="0.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="1.47" />
					<actual value="1.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1.50" />
					<actual value="1.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="93.00" />
					<actual value="93.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="93.00" />
					<actual value="94.80" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="93.00" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="93.00" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="93.00" />
					<actual value="93.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="93.00" />
					<actual value="94.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="93.00" />
					<actual value="94.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="93.00" />
					<actual value="93.60" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="93.00" />
					<actual value="95.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="89.30" />
					<actual value="68.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="47.52" />
					<actual value="23.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="44.63" />
					<actual value="25.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="95.00" />
					<actual value="50.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="41.27" />
					<actual value="27.70" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="44.63" />
					<actual value="42.90" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="82.50" />
					<actual value="51.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="47.52" />
					<actual value="27.50" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="41.27" />
					<actual value="23.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults (15 and above) on ART among all adults living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="94.50" />
					<actual value="92.70" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="94.63" />
					<actual value="93.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="94.49" />
					<actual value="92.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="94.63" />
					<actual value="92.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="94.49" />
					<actual value="90.50" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="94.49" />
					<actual value="91.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="94.60" />
					<actual value="93.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="94.50" />
					<actual value="91.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="94.49" />
					<actual value="88.60" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="72.00" />
					<actual value="53.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="79.00" />
					<actual value="59.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="86.00" />
					<actual value="73.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="39.50" />
					<actual value="26.10" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="79.00" />
					<actual value="59.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="43.00" />
					<actual value="37.20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="86.00" />
					<actual value="73.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="36.00" />
					<actual value="27.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="72.00" />
					<actual value="53.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="44.63" />
					<actual value="41.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.30" />
					<actual value="108.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="45.13" />
					<actual value="51.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="88.26" />
					<actual value="85.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="89.30" />
					<actual value="91.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="89.26" />
					<actual value="91.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="44.13" />
					<actual value="43.80" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.26" />
					<actual value="108.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="88.30" />
					<actual value="85.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="98.10" />
					<actual value="92.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="98.15" />
					<actual value="96.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="98.15" />
					<actual value="89.10" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="98.15" />
					<actual value="92.90" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="98.15" />
					<actual value="90.00" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="97.91" />
					<actual value="93.50" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="98.10" />
					<actual value="90.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="97.90" />
					<actual value="93.50" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="98.50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="99.60" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="98.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="99.50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="100.00" />
					<actual value="99.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="96.40" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="97.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="98.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="98.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="96.90" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="96.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="93.20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="97.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="98.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV newly initiated on ART who were screened for TB</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="100.00" />
					<actual value="43.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="80.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="100.00" />
					<actual value="70.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="100.00" />
					<actual value="86.70" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="77.50" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="100.00" />
					<actual value="85.90" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="84.50" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="100.00" />
					<actual value="60.30" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="100.00" />
					<actual value="75.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="83" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="83" />
					<actual value="23" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="210" />
					<actual value="47" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="130" />
					<actual value="20" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="260" />
					<actual value="50" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="166" />
					<actual value="46" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="105" />
					<actual value="24" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="130" />
					<actual value="30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="105" />
					<actual value="23" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of pregnant women who know their HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="42.75" />
					<actual value="50.70" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="40.38" />
					<actual value="48.40" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="40.38" />
					<actual value="51.40" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="80.80" />
					<actual value="99.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="42.75" />
					<actual value="52.40" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="45.12" />
					<actual value="45.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="85.50" />
					<actual value="103.10" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="90.20" />
					<actual value="92.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="45.12" />
					<actual value="47.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="4900" />
					<actual value="4240" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="4050" />
					<actual value="3257" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="4900" />
					<actual value="3741" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="8910" />
					<actual value="7757" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="8100" />
					<actual value="6874" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="4050" />
					<actual value="3617" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9800" />
					<actual value="7981" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="4455" />
					<actual value="3764" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="4455" />
					<actual value="3993" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="93.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="68.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="72.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="42.50" />
					<actual value="38.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="75.00" />
					<actual value="72.80" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="40.00" />
					<actual value="25.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="85.00" />
					<actual value="93.80" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="37.50" />
					<actual value="27.70" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="80.00" />
					<actual value="68.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of children (under 15) on ART among all children living with HIV at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="60.59" />
					<actual value="33.50" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.59" />
					<actual value="33.10" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="51.43" />
					<actual value="35.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="60.59" />
					<actual value="37.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="51.40" />
					<actual value="35.30" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="60.59" />
					<actual value="37.40" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="60.60" />
					<actual value="33.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="51.43" />
					<actual value="36.00" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="60.60" />
					<actual value="37.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="75.00" />
					<actual value="79.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="850" />
					<actual value="164" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="1000" />
					<actual value="229" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="425" />
					<actual value="99" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="675" />
					<actual value="134" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1350" />
					<actual value="289" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1000" />
					<actual value="182" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="425" />
					<actual value="65" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2000" />
					<actual value="411" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="675" />
					<actual value="155" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TCP-Other 1: Number of children below 5 living with HIV and/or in contact with TB patients whi started preventive treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="1758" />
					<actual value="1010" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="834" />
					<actual value="395" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="950" />
					<actual value="569" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="879" />
					<actual value="424" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="1668" />
					<actual value="746" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="879" />
					<actual value="586" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="950" />
					<actual value="569" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="834" />
					<actual value="351" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="44.90" />
					<actual value="648.90" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="39.96" />
					<actual value="433.10" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="19.98" />
					<actual value="232.30" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="50.00" />
					<actual value="919.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="50.00" />
					<actual value="919.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="22.47" />
					<actual value="253.60" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="44.94" />
					<actual value="648.90" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="25.00" />
					<actual value="395.60" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="40.00" />
					<actual value="433.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-06-30" />
					<target value="5.02" />
					<actual value="53.20" />
				</period>
				<period>
					<period-start iso-date="2021-01-01" />
					<period-end iso-date="2021-12-31" />
					<target value="10.00" />
					<actual value="134.20" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="7.87" />
					<actual value="145.90" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="22.53" />
					<actual value="248.60" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="11.26" />
					<actual value="110.80" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-12-31" />
					<target value="22.50" />
					<actual value="248.60" />
				</period>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-12-31" />
					<target value="15.70" />
					<actual value="285.30" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="15.73" />
					<actual value="285.30" />
				</period>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="10.04" />
					<actual value="134.20" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for BDI-C-UNDPP02</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="90.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="90.00" />
					<actual value="91.30" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="90.00" />
					<actual value="91.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="63.00" />
					<actual value="53.67" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="70.00" />
					<actual value="59.67" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="78.00" />
					<actual value="54.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV and on ART who are virologically suppressed</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="64.00" />
					<actual value="92.77" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="86.10" />
					<actual value="89.41" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="75.20" />
					<actual value="91.83" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2021-07-01" />
					<period-end iso-date="2021-12-31" />
					<target value="44.00" />
					<actual value="11.33" />
				</period>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="54.00" />
					<actual value="19.58" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="66.00" />
					<actual value="19.17" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV who know their HIV status at the end of the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="96.00" />
					<actual value="89.00" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="97.40" />
					<actual value="92.08" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="98.00" />
					<actual value="93.44" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for BDI-C-UNDPP02</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of AIDS-related deaths per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="10.9" />
					<actual value="1356" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="10" />
					<actual value="1257" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9.4" />
					<actual value="1058" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of new HIV infections per 1000 uninfected population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="0.1" />
					<actual value="0.16" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="0.1" />
					<actual value="0.12" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="0.1" />
					<actual value="0.12" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months</narrative>
				</title>
				<period>
					<period-start iso-date="2022-01-01" />
					<period-end iso-date="2022-06-30" />
					<target value="7.29" />
					<actual value="17.95" />
				</period>
				<period>
					<period-start iso-date="2023-01-01" />
					<period-end iso-date="2023-06-30" />
					<target value="7.28" />
					<actual value="10.79" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="7.28" />
					<actual value="19.38" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="2.40" />
					<actual value="1.40" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.40" />
					<actual value="1.60" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="2.40" />
					<actual value="1.60" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2022-07-01" />
					<period-end iso-date="2022-12-31" />
					<target value="13" />
					<actual value="20" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="11" />
					<actual value="17" />
				</period>
				<period>
					<period-start iso-date="2023-07-01" />
					<period-end iso-date="2023-12-31" />
					<target value="9" />
					<actual value="17" />
				</period>
			</indicator>
		</result>
	</iati-activity>
	<iati-activity last-updated-datetime="2026-02-14T00:00:00+01:00" xml:lang="en" default-currency="USD" humanitarian="false" hierarchy="1">
		<iati-identifier>47045-BDI-C-UNDP-1</iati-identifier>
		<reporting-org ref="47045" type="30" secondary-reporter="false">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</reporting-org>
		<title>
			<narrative xml:lang="en">Continued scale-up of diagnostic and treatment services for HIV and TB, at health facility and community levels - Burundi (01-Jan-2018-31-Dec-2020)</narrative>
		</title>
		<description type="1">
			<narrative xml:lang="en">Burundi, TB/HIV, United Nations Development Programme (UNDP Burundi)This program has the following goals: Contribuer à l’amélioration de la santé de la population burundaise en réduisant le fardeau lié à la tuberculose.  Les nouvelles infections à VIH sont réduites de 19% de 2018 à 2022.  La mortalité liée au VIH et  au SIDA est réduite de 34% de 2018 à 2022. The objectives of this program are: Augmenter la détection précoce de 7662 cas à 9313 cas de TB TTF dans la population générale y compris les groupes à hauts risques (PVVIH, Réfugiés, prisonniers, enfants) soit une augmentation de 18% de 2016 à 2020.  Augmenter le dépistage des cas TB/MR en passant de 80 en 2016 à 165 cas TB/MR attendus selon l’estimation OMS soit une augmentation de 85 cas  de 2016 à 2020.  Maintenir le taux de succès thérapeutique des nouveaux patients bactériologique ment confirmés et des cas TB/MR à plus de 90%.  Améliorer la prévention de la tuberculose (contrôle de l’infection dans les établissements de soins, le changement de comportement dans la population générale et la prévention par des médicaments), de sorte que le pourcentage de la population ayant une connaissance adéquate de la tuberculose passe de 76% à 90% en 2020.  Améliorer les capacités de gestion du programme de lutte antituberculeuse: améliorer la surveillance, le système de suivi/évaluation et de recherche opérationnelle..  La couverture des soins ARV de qualité est augmentée de 60%(2018) à 85%(2022) chez les enfants de 0 à 14 ans et de 75% (2018) à 95%(2022) chez les adultes.   % de PVVIH (d'adultes et d'enfants) qui ont commencé la therapie antiretrovirale qui ont une une charge virale indectable à 12 mois (inferieure à 1000 copies /ml ) est augmentée de 86 % à 89%.  La prévention à l’INH chez 95% des PVVIH screennées TB négative et le traitement de la TB sont assurés chez 95 % des PVVIH coïnfectés par la  TB.  La couverture en ARV pour la PTME passe de 95% (2018) à 99% (2022) pour les femmes et  de 95% (2018) à 99% (2022) pour les nouveau nés des femmes séropositives</narrative>
		</description>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org ref="47045" type="30" role="1">
			<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
		</participating-org>
		<participating-org type="40" role="2">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="3">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<participating-org type="40" role="4">
			<narrative xml:lang="en">United Nations Development Programme</narrative>
		</participating-org>
		<other-identifier ref="BDI-C-UNDPP01" type="A1">
			<owner-org ref="47045">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</owner-org>
		</other-identifier>
		<activity-status code="3" />
		<activity-date type="1" iso-date="2018-01-01" />
		<activity-date type="2" iso-date="2018-01-01" />
		<activity-date type="3" iso-date="2020-12-31" />
		<activity-date type="4" iso-date="2020-12-31" />
		<contact-info type="1">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en"> </narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="2">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Grant Management Division</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Gilles, CESARI</narrative>
			</person-name>
			<job-title>
				<narrative xml:lang="en">Fund Portfolio Manager</narrative>
			</job-title>
			<telephone>+41 58 791 1700</telephone>
			<email>gilles.cesari@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<contact-info type="4">
			<organisation>
				<narrative xml:lang="en">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
			</organisation>
			<department>
				<narrative xml:lang="en">Communications</narrative>
			</department>
			<person-name>
				<narrative xml:lang="en">Web Team</narrative>
			</person-name>
			<telephone>+41 58 791 1700</telephone>
			<email>website@theglobalfund.org</email>
			<website>https://www.theglobalfund.org</website>
			<mailing-address>
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
			</mailing-address>
		</contact-info>
		<activity-scope code="4" />
		<recipient-country code="BI" percentage="100">
			<narrative xml:lang="en">Burundi</narrative>
		</recipient-country>
		<sector vocabulary="1" code="13040" percentage="64">
			<narrative xml:lang="en">HIV</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="22">
			<narrative xml:lang="en">Multicomponent</narrative>
		</sector>
		<sector vocabulary="1" code="12110" percentage="4">
			<narrative xml:lang="en">RSSH</narrative>
		</sector>
		<sector vocabulary="1" code="12263" percentage="10">
			<narrative xml:lang="en">Tuberculosis</narrative>
		</sector>
		<country-budget-items vocabulary="4">
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Behavioral interventions for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Condoms and lubricant programming for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for MSM -&gt; Other intervention(s) for MSM</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Behavioral interventions for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Condoms and lubricant programming for PWID</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for people who inject drugs (PWID) and their partners -&gt; Other intervention(s) for IDUs and their partners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Behavioral interventions for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Condoms and lubricant programming for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; HIV testing services for sex workers</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive prevention programs for sex workers and their clients -&gt; Other intervention(s) for sex workers and their clients</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Comprehensive programs for people in prisons and other closed settings -&gt; Condoms and lubricant programming for people in prisons and other closed settings</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">HIV -&gt; Differentiated HIV Testing Services -&gt; Differentiated HIV testing services</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Other intervention(s) for PMTCT</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="4">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; PMTCT -&gt; Prong 4: Treatment, care and support to mothers living with HIV, their children and families</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Male and Female condoms for adolescents and youth, in and out of school</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for general population -&gt; Behavioral interventions as part of programs for general population</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for general population -&gt; Gender-based violence prevention and treatment programs for general population</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for general population -&gt; Other intervention(s) for general population</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; HIV testing services for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">HIV -&gt; Prevention programs for other vulnerable populations -&gt; Male and female condoms for other vulnerable populations</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="8">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="3">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="27">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; HIV care</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="6">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Prevention, diagnosis and treatment of opportunistic infections</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Drug resistance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; COVID-19 control and containment including health systems strengthening</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; COVID-19 -&gt; Risk mitigation for disease programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="18">
				<description>
					<narrative xml:lang="en">Multicomponent -&gt; Program management -&gt; Grant management</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Integrated service delivery and quality improvement -&gt; Laboratory systems for disease prevention, control, treatment and disease surveillance</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="5">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="0">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="2">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
				</description>
			</budget-item>
			<budget-item code="5.1.1" percentage="1">
				<description>
					<narrative xml:lang="en">Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
				</description>
			</budget-item>
		</country-budget-items>
		<collaboration-type code="1" />
		<default-flow-type code="10" />
		<default-finance-type code="110" />
		<default-aid-type code="C01" />
		<default-tied-status code="5" />
		<budget type="2" status="2">
			<period-start iso-date="2018-01-01" />
			<period-end iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-01-01">6103880.88</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2020-01-01" />
			<period-end iso-date="2020-12-31" />
			<value currency="USD" value-date="2018-01-01">18377710.48</value>
		</budget>
		<budget type="2" status="2">
			<period-start iso-date="2019-01-01" />
			<period-end iso-date="2019-12-31" />
			<value currency="USD" value-date="2018-01-01">11163212.83</value>
		</budget>
		<transaction ref="8a65073b-11d7-4441-98e8-6f415d494974">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-05-05" />
			<value currency="USD" value-date="2020-05-05">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b0a62fac-d2b4-4014-89c7-6ebca728b49a">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-11-12" />
			<value currency="USD" value-date="2020-11-12">-6695.28</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9526c8dd-9da6-405b-9e36-cd56437d0866">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-05-07" />
			<value currency="USD" value-date="2019-05-07">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b9f30a47-d9c9-4bf9-a6a0-23f430ef266c">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-01-07" />
			<value currency="USD" value-date="2021-01-07">-22431.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="44f41097-4e5b-45a5-bb46-8ff1a7d8df2c">
			<transaction-type code="2" />
			<transaction-date iso-date="2017-12-19" />
			<value currency="USD" value-date="2017-12-19">17644578.38</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="926db89f-d5e5-4ec5-a83e-292c6c198c17">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-10-02" />
			<value currency="USD" value-date="2019-10-02">14678749.06</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="66fb3efa-883a-4210-a8e5-fbc255d9fd3d">
			<transaction-type code="2" />
			<transaction-date iso-date="2021-02-26" />
			<value currency="USD" value-date="2021-02-26">-3018.01</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="118b235c-48af-434b-ae97-968496a305fd">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-07-25" />
			<value currency="USD" value-date="2020-07-25">-2327907.24</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9507e288-2f62-4688-87ad-622b8ba93816">
			<transaction-type code="2" />
			<transaction-date iso-date="2020-07-25" />
			<value currency="USD" value-date="2020-07-25">3752728.14</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f4ad2faa-d670-4969-96c2-2a9052c67d4b">
			<transaction-type code="2" />
			<transaction-date iso-date="2018-03-20" />
			<value currency="USD" value-date="2018-03-20">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="f5ca867e-f577-47ca-9ed3-6366cb32c1fc">
			<transaction-type code="2" />
			<transaction-date iso-date="2022-05-20" />
			<value currency="USD" value-date="2022-05-20">-974219.54</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="30fdd7fe-22cc-416b-beb6-1fb497478bf6">
			<transaction-type code="2" />
			<transaction-date iso-date="2019-10-02" />
			<value currency="USD" value-date="2019-10-02">-22107.04</value>
			<description>
				<narrative xml:lang="en">Global Fund Commitment to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="b267cd2d-9fec-4bf5-9bcd-2820ff2758eb">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-03-24" />
			<value currency="USD" value-date="2020-03-24">4483586.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="9daaa687-c79c-45ca-ad6f-fd02c08eeede">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-07-29" />
			<value currency="USD" value-date="2020-07-29">2778508.60</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e5149f5f-d884-4b77-b98a-4ff3938b072f">
			<transaction-type code="7" />
			<transaction-date iso-date="2021-02-22" />
			<value currency="USD" value-date="2021-02-22">-3018.01</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="e63dbd95-bb85-421f-83fa-95be0d272fa6">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-03" />
			<value currency="USD" value-date="2019-10-03">4852778.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="561a513e-13fe-4887-9ccf-fc7ecc6fdfa1">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-11-15" />
			<value currency="USD" value-date="2018-11-15">1327218.58</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="288b2f56-060f-4f04-8964-8758805d67eb">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-12-31" />
			<value currency="USD" value-date="2018-12-31">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="99b8ca53-f59a-4552-aca5-c651bd1b8800">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-10-10" />
			<value currency="USD" value-date="2019-10-10">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="42d57664-1751-4c52-b3c2-b072912f5ddc">
			<transaction-type code="3" />
			<transaction-date iso-date="2017-12-20" />
			<value currency="USD" value-date="2017-12-20">4298066.74</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="5bccc5b5-1f47-4cdd-a68a-e743e9fbb690">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-03-26" />
			<value currency="USD" value-date="2019-03-26">5988756.53</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a7f09d2b-9961-40bc-bd64-49dd4f12c2a2">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-12-05" />
			<value currency="USD" value-date="2019-12-05">3014477.82</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="6c8259b2-643b-4180-9b94-a9c7dcf743c0">
			<transaction-type code="7" />
			<transaction-date iso-date="2020-11-09" />
			<value currency="USD" value-date="2020-11-09">-6695.28</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="2a73f2e3-3341-4bf1-be61-88d4d8a7d4d0">
			<transaction-type code="7" />
			<transaction-date iso-date="2020-12-31" />
			<value currency="USD" value-date="2020-12-31">-22431.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</provider-org>
			<receiver-org type="40">
				<narrative xml:lang="en">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="a75c8931-1bda-4323-8275-2a974a767f1a">
			<transaction-type code="3" />
			<transaction-date iso-date="2018-08-24" />
			<value currency="USD" value-date="2018-08-24">1843806.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="4b02291e-0026-4542-ba04-4cf4f2942588">
			<transaction-type code="3" />
			<transaction-date iso-date="2019-08-13" />
			<value currency="USD" value-date="2019-08-13">4164623.49</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<transaction ref="cb6b9de1-a14a-4aa5-9715-637582983aba">
			<transaction-type code="3" />
			<transaction-date iso-date="2020-11-27" />
			<value currency="USD" value-date="2020-11-27">25000.00</value>
			<description>
				<narrative xml:lang="en">Global Fund disbursement to BDI-C-UNDPP01.</narrative>
			</description>
			<provider-org type="40">
				<narrative xml:lang="en">Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
			</provider-org>
			<receiver-org>
				<narrative xml:lang="en">United Nations Development Programme (UNDP Burundi)</narrative>
			</receiver-org>
			<aid-type code="C01" />
			<tied-status code="5" />
		</transaction>
		<document-link url="https://data.theglobalfund.org/grant/BDI-C-UNDP" format="text/html">
			<title>
				<narrative xml:lang="en">Grant page on the data portal of the Global Fund.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">An overview of a grant over it's lifetime.</narrative>
			</description>
			<category code="A12" />
			<category code="A02" />
			<category code="A01" />
			<category code="A07" />
			<category code="A05" />
			<category code="A08" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
			<title>
				<narrative xml:lang="en">Grant terms and conditions.</narrative>
			</title>
			<description>
				<narrative xml:lang="en">General terms and conditions which apply to Global Fund grants.</narrative>
			</description>
			<category code="A04" />
			<document-date iso-date="2026-02-14" />
		</document-link>
		<result type="1" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Coverage / Output indicators targets and results for BDI-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="60.00" />
					<actual value="46.40" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="70.00" />
					<actual value="50.70" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="60.00" />
					<actual value="44.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="80.00" />
					<actual value="34.10" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="70.00" />
					<actual value="47.60" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="80.00" />
					<actual value="45.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="40.00" />
					<actual value="55.30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="35.00" />
					<actual value="64.60" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="37.50" />
					<actual value="15.30" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="35.00" />
					<actual value="6.10" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="37.50" />
					<actual value="19.40" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="40.00" />
					<actual value="23.80" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of pregnant women who know their HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="90.00" />
					<actual value="73.10" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="95.00" />
					<actual value="67.60" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="80.00" />
					<actual value="72.20" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.00" />
					<actual value="69.50" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="95.00" />
					<actual value="71.20" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="80.00" />
					<actual value="78.90" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="78.5" />
					<actual value="35" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="78.5" />
					<actual value="29" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="82.5" />
					<actual value="32" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="73.5" />
					<actual value="20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="82.5" />
					<actual value="30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="73.5" />
					<actual value="30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="35.00" />
					<actual value="28.40" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="35.50" />
					<actual value="28.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="72.00" />
					<actual value="64.80" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="71.00" />
					<actual value="63.30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="70.00" />
					<actual value="51.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="36.00" />
					<actual value="34.20" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="737.5" />
					<actual value="615" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="833" />
					<actual value="637" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="737.5" />
					<actual value="599" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="833" />
					<actual value="643" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="670.5" />
					<actual value="455" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="670.5" />
					<actual value="501" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-exposed infants receiving a virological test for HIV within 2 months of birth</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="75.00" />
					<actual value="10.50" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="72.00" />
					<actual value="39.30" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="75.00" />
					<actual value="62.80" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="80.00" />
					<actual value="39.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="80.00" />
					<actual value="30.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="72.00" />
					<actual value="18.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="96.00" />
					<actual value="112.10" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="95.00" />
					<actual value="75.20" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="95.00" />
					<actual value="79.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="97.00" />
					<actual value="89.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="97.00" />
					<actual value="69.80" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="96.00" />
					<actual value="114.30" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="1267" />
					<actual value="182" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="1330.5" />
					<actual value="245" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="1330.5" />
					<actual value="174" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1397" />
					<actual value="142" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="1397" />
					<actual value="154" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="1267" />
					<actual value="82" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of ART sites that had a stock-out of any antiretroviral drugs during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="5.00" />
					<actual value="11.20" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="5.00" />
					<actual value="8.50" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="5.00" />
					<actual value="7.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="5.00" />
					<actual value="9.50" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="5.00" />
					<actual value="3.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="5.00" />
					<actual value="24.30" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="100.00" />
					<actual value="98.20" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="100.00" />
					<actual value="98.80" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="96.00" />
					<actual value="99.60" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="96.00" />
					<actual value="98.20" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="96.00" />
					<actual value="99.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="96.00" />
					<actual value="99.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="96.00" />
					<actual value="99.70" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="96.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of people who were tested for HIV and received their results during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="1097727" />
					<actual value="982024" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="1075350" />
					<actual value="2008439" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1120952" />
					<actual value="842311" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="560476" />
					<actual value="408173" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="537675" />
					<actual value="938645" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="548863.5" />
					<actual value="567110" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="39.50" />
					<actual value="41.40" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="79.00" />
					<actual value="97.70" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="41.50" />
					<actual value="82.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="81.20" />
					<actual value="137.60" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="83.00" />
					<actual value="141.60" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="40.50" />
					<actual value="69.50" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="4223.5" />
					<actual value="3375" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="4435" />
					<actual value="3468" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="4656.5" />
					<actual value="3646" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="4656.5" />
					<actual value="3569" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="4435" />
					<actual value="3359" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="4223.5" />
					<actual value="3827" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="92.30" />
					<actual value="94.30" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="92.30" />
					<actual value="94.50" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="92.30" />
					<actual value="94.70" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="92.30" />
					<actual value="93.90" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="92.30" />
					<actual value="93.40" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="92.30" />
					<actual value="93.70" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="96.00" />
					<actual value="98.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="96.00" />
					<actual value="95.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="96.00" />
					<actual value="97.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="96.00" />
					<actual value="99.30" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="96.00" />
					<actual value="99.80" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="96.00" />
					<actual value="99.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="42.50" />
					<actual value="40.00" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="41.50" />
					<actual value="45.90" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="83.00" />
					<actual value="85.30" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="85.00" />
					<actual value="84.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="87.00" />
					<actual value="98.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="43.50" />
					<actual value="49.20" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="100.00" />
					<actual value="0.00" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="100.00" />
					<actual value="95.40" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="100.00" />
					<actual value="98.20" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100.00" />
					<actual value="94.80" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="100.00" />
					<actual value="90.70" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="100.00" />
					<actual value="0.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="100.00" />
					<actual value="98.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="100.00" />
					<actual value="100.00" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="68.00" />
					<actual value="61.30" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="69.00" />
					<actual value="79.80" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="33.50" />
					<actual value="24.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="33.90" />
					<actual value="30.60" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="34.50" />
					<actual value="41.80" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="67.00" />
					<actual value="60.10" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="74.40" />
					<actual value="81.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="74.90" />
					<actual value="90.10" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="74.90" />
					<actual value="87.80" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="74.00" />
					<actual value="75.70" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="74.40" />
					<actual value="75.90" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="74.00" />
					<actual value="74.70" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
				</title>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="82.5" />
					<actual value="32" />
				</period>
				<period>
					<period-start iso-date="2018-01-01" />
					<period-end iso-date="2018-06-30" />
					<target value="73.5" />
					<actual value="20" />
				</period>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="78.5" />
					<actual value="29" />
				</period>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="73.5" />
					<actual value="30" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="82.5" />
					<actual value="30" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="78.5" />
					<actual value="35" />
				</period>
			</indicator>
		</result>
		<result type="3" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Impact indicators targets and results for BDI-C-UNDPP01</narrative>
			</title>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB incidence rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="107" />
					<actual value="111" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="102" />
					<actual value="107" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="98" />
					<actual value="107" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">RR-TB and/or MDR-TB prevalence among new TB patients: Proportion of new TB patients with RR-TB and/or MDR-TB</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="2.2" />
					<actual value="2.4" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2" />
					<actual value="2.5" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="1.8" />
					<actual value="2.5" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB mortality rate per 100,000 population</narrative>
				</title>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="3" />
					<actual value="19" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2.3" />
					<actual value="21" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2.7" />
					<actual value="21" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Estimated percentage of children newly infected with HIV from mother-to-child transmission among women living with HIV delivering in the past 12 months</narrative>
				</title>
				<period>
					<period-start iso-date="2019-01-01" />
					<period-end iso-date="2019-06-30" />
					<target value="2.00" />
					<actual value="1.02" />
				</period>
				<period>
					<period-start iso-date="2020-01-01" />
					<period-end iso-date="2020-06-30" />
					<target value="2.00" />
					<actual value="17.34" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="2.00" />
					<actual value="7.43" />
				</period>
			</indicator>
		</result>
		<result type="2" aggregation-status="false">
			<title>
				<narrative xml:lang="en">Outcome indicators targets and results for BDI-C-UNDPP01</narrative>
			</title>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">TB treatment coverage: Percentage of patients with new and relapse TB that were notified and treated among the estimated number of incident TB in the same year (all forms of TB - bacteriologically confirmed plus clinically diagnosed</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="73.91" />
					<actual value="62.43" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="79.39" />
					<actual value="61.11" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="84.73" />
					<actual value="77.47" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="79" />
					<actual value="67.57" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="81" />
					<actual value="56.68" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="83" />
					<actual value="58.61" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Notification of RR-TB and/or MDR-TB cases – Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="70.00" />
					<actual value="23.81" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="70.09" />
					<actual value="40.76" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="69.92" />
					<actual value="37.58" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="90.48" />
					<actual value="90.00" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="90.30" />
					<actual value="93.75" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="90.45" />
					<actual value="92.00" />
				</period>
			</indicator>
			<indicator measure="1" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse</narrative>
				</title>
				<period>
					<period-start iso-date="2018-07-01" />
					<period-end iso-date="2018-12-31" />
					<target value="7426.46" />
					<actual value="7320" />
				</period>
				<period>
					<period-start iso-date="2019-07-01" />
					<period-end iso-date="2019-12-31" />
					<target value="7797.5" />
					<actual value="6755" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="8187.01" />
					<actual value="6407" />
				</period>
			</indicator>
			<indicator measure="2" aggregation-status="false">
				<title>
					<narrative xml:lang="en">Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy</narrative>
				</title>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="93.00" />
					<actual value="77.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="92.00" />
					<actual value="77.40" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="92.00" />
					<actual value="77.12" />
				</period>
				<period>
					<period-start iso-date="2020-07-01" />
					<period-end iso-date="2020-12-31" />
					<target value="93.00" />
					<actual value="77.12" />
				</period>
			</indicator>
		</result>
	</iati-activity>
</iati-activities>